Evan B. Shereck, M.D., M.Ed

  • Professor of Pediatrics, Division of Hematology and Oncology, School of Medicine
  • Program Director, Pediatric Hematology/Oncology Fellowship
  • Associate Director, Cancer Research Training, Knight Cancer Institute
  • Block Co-Director, Blood and Host Defense

Biography

Dr. Evan Shereck specializes in caring for children with bone marrow failure and immunodeficiencies, along with children undergoing bone marrow transplantation. She also directs clinical trials for patients with bone marrow failure disorders and immunodeficiencies. Dr. Shereck is also passionate about teaching – from children in elementary school to retired faculty. She holds many education leadership positions at OHSU.

When she's not working, Dr. Shereck enjoys hiking, skiing, going on road trips and finishing New York Times crossword puzzles. She also enjoys spending time with her husband and two children.

Education and training

    • M.D., 2001, Rutgers Robert Wood Johnson Medical School
    • M.Ed., 2016, University of Cincinnati

  • Residency

    • Pediatrics, Columbia University, New York, NY, 2004

  • Fellowship

    • Fellowship in pediatric hematology/oncology, Columbia University, New York, NY, 2007

  • Certifications

    • American Board of Pediatrics (general pediatrics), 2004
    • American Board of Pediatrics, sub-board of Pediatric Hematology/Oncology, 2009

Memberships and associations:

  • American Society of Hematology
  • American Society of Pediatric Hematology/Oncology
  • American Society for Blood and Marrow Transplantation
  • Children's Oncology Group
  • Pediatric Blood and Marrow Transplant Consortium
  • Primary Immune Deficiency Treatment Consortium

Areas of interest

  • Pediatric Bone Marrow Transplant
  • Bone Marrow Failure
  • Immunodeficiency
  • Innovations in Education

Publications

Elsevier pure profile

Selected publications

  • Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report. Blood, 2019.
  • Survival trends in infants undergoing allogeneic hematopoietic cell transplant. JAMA Pediatr. 2019.
  • A Conceptual Framework and Key Research Questions in Educational Needs of Blood and Marrow Transplant Patients, Caregivers and Families.  Biology of Blood and Marrow Transplantation 2019
  • The Genetic landscape of SCID in the US and Canada in the current era (2010-2018). J. Allergy Clin Immunol. 2019
  • SCID genotype and 6 month post-transplant CD4 count predict survival and immune recovery: a PIDTC retrospective study. Blood 2018
  • Immune reconstitution and survival of 100 SCID patients post hematopoietic cell transplant: A PIDTC prospective study. Blood. 2017
  • Measuring pediatric hematology-oncology fellows’ skills in humanism and professionalism: A novel assessment instrument. Pediatric Blood and Cancer. 2017
  • Humanism and professionalism education for pediatric hematology-oncology fellows: A model for pediatric subspecialty training. Pediatric Blood and Cancer. 2015
  • Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplant Physicians: the National Marrow Donor Program’s System Capacity Initiative Physician Workforce Group Report. Biology of Blood and Marrow Transplantation. 2014
  • Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia. Pediatr Blood Cancer. 2013

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}